India, July 29 -- Today's top biotech gainers include SciSparc, after its subsidiary successfully completed internal validation of a proprietary quantum sampling platform designed to analyze clinical trial data; Avantor, following the release of its second-quarter financial results and an upbeat outlook; and NeoGenomics, after raising its full-year guidance, among others.
Read on.
SPRC Achieves Quantum Analytics Milestone
SciSparc Ltd. (SPRC) led the pack of gainers on Wednesday following the announcement that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) has successfully completed internal validation of its proprietary quantum sampling platform for analyzing clinical trial data.
The platform is being advanced by CliniQuantum, a quan...